Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme: The West Birmingham Atrial Fibrillation Project
Introduction
Despite the overwhelming evidence from clinical trials that thromboprophylaxis with warfarin reduces the incidence of stroke and mortality, such therapy remains under-utilised [1], [2], [3]. Patients' beliefs about their healthcare are important factors that influence their decision to accept, decline, or comply with anticoagulant therapy, particularly warfarin [4], [5]. Patients need to understand the importance of attending for regular blood tests, to maintain the INR at an optimal level to prevent bleeding or a stroke, and the interactions of warfarin with antibiotics, alcohol, and foods rich in vitamin K [1], [6]. However, previous studies have demonstrated that many patients with AF possess very little knowledge of their disease [7], [8] and do not understand the risks and/or benefits of anticoagulant therapy [7], [8], [9], [10].
The paucity in patient's knowledge concerning AF could be attributed to the lack of information and explanations given by healthcare professionals due to the time constraints of outpatient clinics, the lack of appropriate educational literature, and the risk/benefit analogies employed by physicians [9]. Evidence suggests that compliance is improved if patients know what they have been prescribed, the reasons for taking it, what will happen if they fail to adhere as prescribed, any factors which may alter drug efficacy, and any possible side effects [11]. Patient education about the consequences of untreated disease and the importance of adhering to the medication regimen is vital to ensure compliance and disease management [11], [12]. Certainly, educational interventions in other chronic diseases, such as diabetes [13], ulcerative colitis [14], heart failure [15], and epilepsy [16] have demonstrated significant improvements in knowledge [13], [14], symptom monitoring [15], disease management [13], [14], [15], and medication compliance [15], [16].
Despite our previous work examining patient's knowledge of the disease and its treatment [7], [8], we are unaware of any study to date which has examined the effect of an educational intervention in AF patients. The aim of this pilot study was to extend our previous work [7], [8] by examining patient's knowledge and perceptions of AF and their anticoagulant treatment, before and after a brief educational intervention, utilising a specifically designed information booklet on AF.
Section snippets
Materials and methods
Consecutive patients with a documented diagnosis of atrial fibrillation (≥ 3 months ago), currently or previously on warfarin, attending the AF outpatient clinic at the City Hospital, Birmingham, between October 2003 and February 2004, were eligible for inclusion. Socio-demographic and clinical data was recorded from patients' hospital records. The Local Research Ethics Committee approved the study and all participants provided written informed consent.
A standardised questionnaire was devised
Results
Ninety-eight patients were approached over the study period, but five declined participation; reasons given were inability to speak English (n = 1) or return to complete the follow-up questionnaire (n = 4). The study cohort comprised 93 (94.5%) patients (47 men; mean (S.D.) age 67.3 (11.6) years; 89 (95.7%) White Europeans) (see Table 1). The median (IQR) duration of documented AF was 24.0 (15.0–48.0) months. The majority (72%) were currently taking warfarin. Thirty-three (35.5%) patients (12 men;
Discussion
Understanding the nature and consequences of AF and anticoagulant therapy are essential to optimise the management of AF and allow the patient to participate in maintaining their health, in consultation with health professionals. The present study revealed that fewer than half of the patients were able to name their heart condition; considerably less than reported in an earlier study of AF patients [8]. However, in the present study, the majority of patients were aware that AF was a
Acknowledgements
We acknowledge the support of the Sandwell and West Birmingham Hospitals NHS Trust Research and Development programme for the Haemostasis Thrombosis and Vascular Biology Unit. This project is partly funded by an educational non-promotional research project grant from Astra Zeneca, Charnwood, UK, but is a totally independent study.
References (17)
- et al.
Diabetes education and knowledge in patients with type 2 diabetes from the community: the Freemantle diabetes study
J Diabetes Complications
(2003) - et al.
Medication education for patients with epilepsy in Taiwan
Seizure
(2003) - et al.
Why do patients with atrial fibrillation not receive warfarin?
Arch Intern Med
(2000) - et al.
Recent national patterns of warfarin use in atrial fibrillation
Circulation
(1998) - et al.
Under-utilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke
J Am Geriatr Soc
(1998) - et al.
Implementing evidence-based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation
BMJ
(1999) - et al.
The impact of patients' preferences on the treatment of atrial fibrillation: observational study of patient-based decision analysis
BMJ
(2000) - et al.
ABC of antithrombotic therapy: antithrombotic therapy for atrial fibrillation
BMJ
(2002)
Cited by (146)
Knowledge about atrial fibrillation and anticoagulation affects the risk of clinical outcomes
2022, Thrombosis ResearchThe 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
2020, Canadian Journal of CardiologyAtrial fibrillation patients’ experiences and perspectives of anticoagulation therapy changes
2020, Research in Social and Administrative PharmacyClinician-Created Video Education for Patients with AF: A Randomized Clinical Trial
2023, JAMA Network Open